Back

Engineering a 3D Lung Co-culture Platform to Model Epithelial-Fibroblast Interactions in Pulmonary Fibrosis

Mega Jayaseelan, M.; Locke, L.; Ballinger, M.; Skardal, A.

2026-05-13 bioengineering
10.64898/2026.05.07.723587 bioRxiv
Show abstract

Idiopathic pulmonary fibrosis (IPF) is a fatal interstitial lung disease (ILD) characterized by progressive fibrosis, irreversible loss of lung elasticity, and chronic respiratory failure, with a mean survival of 3-5 years. The disease is believed to result from repeated alveolar epithelial injury that sustains transforming growth factor-beta (TGF-{beta}) signaling, driving fibroblast-to-myofibroblast differentiation and excessive collagen deposition. Although current IPF models--including animal studies, 2D cultures, and basic 3D systems--have enhanced understanding of disease mechanisms, they inadequately replicate epithelial-fibroblast interactions, extracellular matrix (ECM) remodeling, and epithelial barrier dysfunction. To address this limitation, we engineered a 3D lung co-culture model that simulates the physiological epithelial-fibroblast crosstalk and ECM remodeling characteristic of IPF. Our model embeds fibroblasts within a collagen-hyaluronic acid matrix overlaid with an epithelial monolayer cultured at an air-liquid interface. Basolateral TGF-{beta} exposure generated a profibrotic microenvironment that weakened epithelial barrier integrity and drove myofibroblast differentiation marked by elevated -SMA and vimentin. Elevated pro-inflammatory cytokine secretion and increased collagen disorganization further demonstrated active fibrogenesis. Together, these features show that our model captures key early events in IPF pathogenesis and offers a versatile platform for next-generation lung-on-a-chip studies in fibrotic disease.

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

1
American Journal of Respiratory Cell and Molecular Biology
38 papers in training set
Top 0.1%
28.6%
2
American Journal of Respiratory and Critical Care Medicine
39 papers in training set
Top 0.1%
18.1%
3
JCI Insight
241 papers in training set
Top 0.3%
7.4%
50% of probability mass above
4
Scientific Reports
3102 papers in training set
Top 33%
3.7%
5
The FASEB Journal
175 papers in training set
Top 0.2%
3.7%
6
Advanced Science
249 papers in training set
Top 7%
2.8%
7
Disease Models & Mechanisms
119 papers in training set
Top 0.6%
2.8%
8
European Respiratory Journal
54 papers in training set
Top 0.6%
2.7%
9
Acta Biomaterialia
85 papers in training set
Top 0.4%
1.8%
10
Nature Communications
4913 papers in training set
Top 50%
1.8%
11
PLOS ONE
4510 papers in training set
Top 52%
1.8%
12
npj Regenerative Medicine
21 papers in training set
Top 0.1%
1.4%
13
eLife
5422 papers in training set
Top 51%
1.0%
14
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 41%
0.9%
15
American Journal of Physiology-Lung Cellular and Molecular Physiology
39 papers in training set
Top 0.4%
0.8%
16
Frontiers in Immunology
586 papers in training set
Top 7%
0.8%
17
Molecular Therapy
71 papers in training set
Top 3%
0.8%
18
ERJ Open Research
44 papers in training set
Top 0.8%
0.8%
19
American Journal of Physiology-Cell Physiology
34 papers in training set
Top 0.3%
0.7%
20
Thorax
32 papers in training set
Top 0.8%
0.7%
21
Life Science Alliance
263 papers in training set
Top 2%
0.7%
22
Annals of Biomedical Engineering
34 papers in training set
Top 1%
0.7%
23
Metabolites
50 papers in training set
Top 1%
0.7%
24
Pediatric Research
18 papers in training set
Top 0.5%
0.5%
25
Bioengineering & Translational Medicine
21 papers in training set
Top 1%
0.5%
26
Journal of The Royal Society Interface
189 papers in training set
Top 6%
0.5%